Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 1.00 |
| ▸ | MIF | P14174 | 9/20 | 0.81 |
| ▸ | MAPT | P10636 | 4/20 | 0.81 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.77 |
| ▸ | PKM | P14618 | 2/20 | 0.77 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.77 |
| ▸ | MAOA | P21397 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CASP3 | P42574 | 2/20 | 0.68 |
| ▸ | RAB9A | P51151 | 2/20 | 0.68 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.68 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.68 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15153677 | 1.00 | MAOB (1.00) | MAOBMIFMAPTCYP19A1PKM | |
| SCHEMBL29546087 | 1.00 | MAOB (1.00) | MAOBMIFMAPTCYP19A1PKM | |
| SCHEMBL980327 | 1.00 | MAOB (1.00) | MAOBMIFMAPTCYP19A1PKM | |
| SCHEMBL29679848 | 1.00 | MAOB (1.00) | MAOBMIFMAPTCYP19A1PKM | |
| SCHEMBL820654 | 1.00 | MAOB (1.00) | MAOBMIFMAPTCYP19A1PKM | |
| SCHEMBL6958006 | 0.90 | MIF (1.00) | MAOBMIFMAPTCYP19A1PKM | |
| SCHEMBL13203410 | 0.90 | MAOB (0.81) | MAOBMIFMAPTCYP19A1PKM | |
| SCHEMBL14033869 | 0.90 | MAOB (0.81) | MAOBMIFMAPTCYP19A1PKM | |
| SCHEMBL8548101 | 0.87 | MAOB (0.77) | MAOBMIFMAPTCYP19A1PKM | |
| SCHEMBL6825622 | 0.87 | CYP19A1 (1.00) | MAOBMIFMAPTCYP19A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114230457-A | 2-benzylidene tetralone derivatives and preparation method and application thereof | 中山大学 | 2022-03-25 | — | — | CN | claimed |
| US-20250374828-A1 | ORGANIC COMPOUND | SEMICONDUCTOR ENERGY LAB (JP) | 2025-12-04 | — | — | US | disclosed |
| US-20250331420-A1 | Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-10-23 | — | — | US | disclosed |
| EP-3709966-B1 | COMPOSITIONS COMPRISING AT LEAST ONE ACRYLIC POLYMER AND AT LEAST ONE INSOLUBLE ORGANIC SCREENING AGENT | OREAL (FR) | 2024-12-11 | — | — | EP | disclosed |
| CN-115925530-B | 3, 4-dihydronaphthalene-1 (2H) -one compound, preparation method and application | 滨州医学院 | 2024-03-12 | — | — | CN | disclosed |
| CN-115925530-A | 3,4-dihydronaphthalene-1 (2H) -ketone compound, preparation method and application | 滨州医学院 | 2023-04-07 | — | — | CN | disclosed |
| CN-114230457-A | 2-benzylidene tetralone derivatives and preparation method and application thereof | 中山大学 | 2022-03-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250374828-A1 | ORGANIC COMPOUND | SUN2, ORC3, EML4 | MAOB 663/4885MIF 3343/4885MAPT 1469/4885 |
| US-20250331420-A1 | Organic Compound | CRY1, CYP1A1, OXER1 | MAOB 1176/4885MIF 3123/4885MAPT 3762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.